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Purpose: To investigate sequence variants in the optineurin (OPTN) gene in patients with juvenile–onset open-angle
glaucoma (JOAG) in Taiwan.
Methods: We analyzed the sequence variants of OPTN in 51 unrelated Taiwanese probands with JOAG and in 51 control
group subjects who did not have JOAG. Genomic DNA was extracted from the individuals and subjected to polymerase
chain reaction (PCR) to amplify all 16 exons and flanking introns of OPTN. The amplified products were then screened
for base variants by autosequence. Data from the two study groups were then compared using Fisher’s exact test and
Armitage's trend test.
Results: Fifteen variants of OPTN were found in the 51 JOAG patients and 51 unrelated normal controls. Two were
missense variants (M98K and K322E), one was a synonymous codon change (T34T), and 12 were changes in the
noncoding sequences. Seven of the variants have been reported and eight were novel. All of the sequence changes were
found in patients with JOAG and in the normal controls except for variant c.-233+25C>G, which was found only in the
control group. Allelic frequencies of these sequence changes did not differ significantly between patients and controls
(p>0.05) except for the variant c.-233+25C>G (p<0.001). Genotype frequencies of c.-233+25C>G was shown to be
significant between the two groups using Fisher’s two-tailed exact test (p<0.001) and Armitage's trend test (p=6.815e
−06).
Conclusions: Our data indicate that none of the mutations in OPTN are associated with JOAG. The variant M98K is not
a risk factor and the variant c.-233+25C>G may be protective against glaucoma in Taiwanese.
Glaucoma is a heterogeneous group of optic neuropathies
that lead to optic nerve atrophy and a permanent loss of vision
[1].  Glaucoma  is  the  second  leading  cause  of  blindness
worldwide with a prevalence of 0.15% in the total population
and approximately 2%–4% in individuals over the age of 40
years [2]. Glaucoma is also a multifarious disease reportedly
caused by the interaction of several environmental and genetic
factors [3]. The most frequent form of glaucoma is primary
open-angle glaucoma (POAG). POAG is a complex disease
of unknown etiology that leads to a progressive loss of the
visual  field.  POAG  has  been  subdivided  into  two  groups
according  to  the  age  at  onset.  Adult-onset  open-angle
glaucoma is a condition typically diagnosed after the age of
40 years; juvenile-onset open-angle glaucoma (JOAG) is a
disease most often diagnosed in patients younger than 35 years
of  age  [4].  The  definition  of  juvenile  glaucoma  is  not
consistent  in  the  literature.  The  condition  is  variously
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described as a subset of infantile glaucoma and as an early
onset form of chronic open-angle glaucoma. Whether this
disease actually represents a distinct clinical entity has also
been questioned by several researchers [5].
At least 14 gene loci (GLC1A-N) have been linked to
POAG  (OMIM  137760).  Among  these  loci,  three  genes
(MYOC encoding myocilin, OPTN encoding optineurin, and
the WDR36 encoding T-cell activation WD repeat-containing
protein [TAWDRP] gene) have been considered to harbor the
mutations that result in POAG [6–12].
Primary open angle glaucoma-1E (GLC1E) is caused by
mutation in the OPTN gene (OMIM 602432). The OPTN gene
locus  was  mapped  to  chromosome  10p15-p14  by  linkage
analysis of the gene in a large British family with a classic
form  of  normal  tension  glaucoma  [9].  The  OPTN  gene
consists of 16 exons; the first three are noncoding exons in the
5′ untranslated region followed by 13 exons that code for a
577 amino acid protein. OPTN is expressed in ocular tissues
such as the retina, trabecular meshwork, and nonpigmented
ciliary  epithelium  [13].  Mutations  in  OPTN,  arguably  the
second POAG gene, were initially found in 16.7% of families
with hereditary and adult-onset POAG and in 12% of sporadic
patients with POAG. The majority of them had an intraocular
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487pressure  (IOP)  of  less  than  22  mmHg  [13].  Mutations  in
OPTN were also found to account for 1.6% of sporadic POAG
in Chinese patients [14].
Previous  studies  in  Western  populations  show  a
significant  racial/ethnic  variation  in  glaucoma  prevalence
between white people and black people, largely related to
variation in the prevalence of primary open-angle glaucoma
(POAG)  [15–17].  Until  recently,  similar  data  have  been
described in Asian populations [18]. Based on the survey of
low vision (WHO criteria), the prevalence of primary open-
angle  glaucoma  in  the  elderly  Chinese  was  about  2%  in
Taiwan [19]. In another study, glaucoma was the leading
cause of low vision and blindness in Taiwan [20]. However,
the gene study of glaucoma just begin to be investigated [21]
and the contribution of variants in OPTN for JOAG in Taiwan
is currently unknown. In this study, we aimed to determine
the variants of the 16 exons and flanking introns of OPTN
using comparative genetic analysis between genomic DNA
from  unrelated  normal  individuals  and  JOAG  patients  in
Taiwan.
METHODS
Subject selection: A total of 1,210 patients who presented to
the  Department  of  Ophthalmology  at  the  Kuo  General
Hospital with symptoms of glaucoma were evaluated. All
study  patients  received  more  than  two  complete  ocular
examinations,  each  comprising  slit-lamp  testing,  IOP
measurement,  a  fundus  examination,  and  a  visual-field
examination. Patients were defined as having JOAG if they
were first diagnosed before the age of 35 years and found to
have an intraocular pressure (IOP) greater than 22 mmHg, a
cup/disc ratio greater than 0.5 or one with an asymmetric
appearance, a visual-field loss characteristic of glaucomatous
change, and an open-angle width ranging from Shaffer grade
II to IV without any other apparent secondary cause (e.g.,
traumatically or surgically induced). Of the 1,210 individuals
screened,  JOAG  was  diagnosed  in  51  unrelated  patients.
These  patients  were  included  in  the  patient  group  for
subsequent OPTN genetic analysis. Most of these subjects
have been reported in a previous study of MYOC mutations in
Taiwanese patients with JOAG [20]. Subjects with mutations
in MYOC were also included in the study.
Fifty-one randomly selected normal individuals over 50
years of age were included as the control group. None of them
featured JOAG. Individuals in the control group also received
complete ocular examinations as described above to exclude
the possibility of glaucoma. The study protocol was approved
by the Institutional Review Board of the Kuo General Hospital
and was performed in accordance with the World Medical
Association's  Declaration  of  Helsinki  (2000).  All  of  the
participants provided signed informed consent to participate
in  the  study  after  details  of  the  study  were  thoroughly
explained to them.
Detection  of  mutations  in  OPTN:  DNA  samples  were
collected from 10 ml of peripheral blood acquired from each
of the 102 individuals and purified using a Gentra DNA Blood
Kit (Gentra Systems Inc., Minneapolis, MN) according to the
manufacturer’s  directions.  The  quality  and  quantity  of
purified  genomic  DNA  were  determined  by  gel
electrophoresis  and  spectrophotometry,  respectively.
Mutations in the 16 exons and flanking introns of OPTN were
screened by direct sequencing (GenBank NT_077569). The
intragenic primers used for polymerase chain reaction (PCR)
are listed in Table 1. In brief, PCR was performed in a reaction
volume of 25 μl containing 100 ng of genomic DNA, 200 μM
dNTP,  0.25  units  of  proTaq  DNA  polymerase  (Promega
Corporation,  Madison,  WI),  and  200  μM  of  intragenic
primers.  The  PCR  products  were  purified  using  a  PCR
Purification Kit (QIAGEN GmbH, Hilden, Germany) and
then  subjected  to  PCR-directed  DNA  sequencing  using  a
DNA  Sequencing  Kit  (Applied  Biosystems  Corporation,
Foster City, CA). Sequencing was performed on an Applied
Biosystems  model  377  automated  sequencer  (Applied
Biosystems Corporation). Sequence data were compared with
the  published  sequence  of  OPTN  (GenBank
NM_001008211 and NT_077569).
Statistical  analysis:  Significant  differences  in  allele
frequencies  between  JOAG  patients  and  controls  were
determined by the Fisher’s two-tailed exact test. The genotype
frequencies  between  JOAG  patients  and  controls  were
determined by Fisher’s two-tailed exact test and Armitage's
trend test. A p value less than 0.05 represented a statistically
significant  difference  between  JOAG  patients  and  control
individuals.  Variants  were  tested  for  Hard-Weinberg
Equilibrium (HWE) using the normal 2×3 Χ2 1 degree of
freedom (df) test of goodness-of-fit to HW proportions.
RESULTS
This  study  surveyed  mutations  in  all  16  exons  of  OPTN
including the flanking intronic sequences and coding region
in 102 Taiwanese individuals. The patient group comprised
51 unrelated patients with JOAG (30 males and 21 females).
The patients ranged in age from 17 to 61 years at the time of
the study. There were 51 unrelated individuals (28 males and
23 females) without any evidence of glaucoma in the control
group. The clinical features of the patients and control subjects
are listed in Table 2.
Fifteen sequence changes of OPTN were found in the 51
JOAG patients and 51 unrelated normal controls (Table 3).
Two were missense changes, one was a synonymous codon
change, and 12 were changes in the noncoding sequence.
Apart  from  T34T,  M98K,  c.553–5C>T,  c.553–10G>A,  c.
626+24G>A, c.779+20G>A, and c.1979–48C>A, the other
eight sequence changes (c.-284G>A, c.-105G.>A, c.964A>G,
c.-233+25C>G,  c.166+66A>G,  c.708–53T>C,  c.
882+109A>G, and c.1978+101A>C) were novel (Table 3).
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488TABLE 2. CLINICAL CHARACTERISTICS OF PARTICIPANTS.
Variable JOAG (n=51) Control (n=51)
Age at the time of the study (mean ± SD) 35.8 ± 10.1 70.4 ± 9.9
Female (%) 41.2 (21/51) 45.1 (23/51)
Male (%) 58.8 (30/51) 54.9 (28/51)
IOP OD (mean ± SD) 18.45 ± 4.16 11.94 ± 2.75
IOP OS (mean ± SD) 19.08 ± 4.22 11.86 ± 3.09
C/D OD (mean ± SD) 0.74 ± 0.14 0.42 ± 0.08
C/D OS (mean ± SD) 0.73 ± 0.15 0.42 ± 0.08
Clinical  characteristics  of  102  Taiwanese  individuals
including  51  JOAG  patients  under  topical  anti-glaucoma
agent medication and 51 unrelated normal controls are listed
in the table. IOP indicates intraocular pressure; C/D indicates
cup-disc ratio of the optic nerve; OD indicates right eye; OS
indicates left eye; and SD indicates standard deviation.
All of the sequence changes were found in the patients with
JOAG  and  in  the  normal  controls  except  for  variant
c.-233+25C>G, which was found only in the control group.
However, the homozygous c.-105G>A variant was observed
in three of the JOAG patients. In contrast, the homozygous
c.-105G>A  variant  was  found  only  in  the  normal  control
individuals (Table 4. M98K was identified in 17 patients with
JOAG  and  in  14  normal  control  individuals.  Five  of  the
patients and two of the control individuals were homozygous
for M98K (Table 4. In addition, the c.A964A<G (K322E)
variant of OPTN was found in all of the patients with JOAG
and in all of the normal controls in our study. All variants were
found  to  be  consistent  with  Hardy–Weinberg  equilibrium
expectations.
To  understand  the  distribution  of  OPTN  sequence
changes in JOAG patients and normal control individuals, we
TABLE 1. OLIGONUCLEOTIDE PRIMER PAIRS FOR POLYMERASE CHAIN REACTION.
Name Oligonucleotide Annealing
temperature (°C)
Region Product size
(bp)
1F AGGGAGCGGCTGGCTGTC 63.5+DMSO Exon 1 302
1R GGCGGGTACCGTTTTCAGG
2F TCCACATGGATGCCTCTACA 60 Exon 2 459
2R TTCCCATGCAAATCTTCAAA
3F CTGGGATTACAGGCGTGAG 54 Exon 3 628
3R GCCTTGCCAAATGCTAAATC Exon 4
5F GGCTAAGCATGGCATCTTTC 64 Exon 5 460
5R CTTCCAAGACCAGGCAAAAC
6F CTCAAAATCCTGGCCTCAAG 64+DMSO Exon 6 575
6R TTCAATTTGCCAGGACATGA
7F ATGGCGAGATGAAACTGACC 62.2 Exon 7 404
7R ATTTGACCTCCGGTGACAAG
8F TTGGAGAATGTTCTGGAAAGC 60.9 Exon 8 485
8R CAGAAAGCACATTGCTTGGA
9F TTTGAAAACCCCTGATCCTTT 62.2 Exon 9 496
9R TTGCAGTGAGCTGAGATCGT
10F GGATTGATTCACCAGCCAGT 62.2 Exon 10 449
10R AAGTTCTCCAGTCCCCAACC
11F CCTTGGGGTTTGTTTAAAAGC 62.2 Exon 11 489
11R TCACCCCACGACCTACTAGC
12F GCTAGTAGGTCGTGGGGTGA 64 Exon 12 420
12R CGCAATAAAGCACATTACACA
13F TATGTTGCCCAGGCTTGTCT 65+DMSO Exon 13 518
13R AGATCCACTGAGCACTTTCCA
14F TGCTATCGGAATGTACCTGGA 60 Exon 14 506
14R TCACATGAAGTGTAAGTGAAGCAA
15F TGAACCTTGGCAGTGTAGTTTG 64 Exon 15 373
15R GATTCGGTGGGTAATGGATG
16F CCTGTGCTCATGTCCCACT  59+DMSO Exon 1  430
16R CTCCCAAAGTGCTGGGATTA
Primers were used in the amplification of OPTN exons and were used in sequencing reactions. Primers located in introns were
placed far enough away from the exon boundaries to allow visualization of the sequence of the splice site. In the table, “F”
indicates the forward strand and “R” indicates the reverse strand. In additional, bp represents base pair and DMSO represents
dimethylsulfoxide in this table.
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489used Fisher’s two-tailed exact test to compare the allelic and
genotypic frequencies of the sequence changes between the
two groups. Genotype frequencies were consistent with HWE
proportions  for  all  variants.  We  found  that  the  allelic
frequencies  of  these  sequence  changes  did  not  differ
significantly between patients and controls (p>0.05) except
for variant c.-233+25C>G (p<0.001; Table 5. However, we
observed  that  the  c.-284G>A  variant  (p=0.023)  and  the
c.-233+25C>G variant (p<0.001) of OPTN was associated
with JOAG whereas the other variants of OPTN were not
associated with JOAG in genotypic frequency analysis using
Fisher’s two-tailed exact test (p>0.05; Table 4. Further, we
used  Armitage's  trend  test  to  compare  the  genotypic
frequencies of the c.-284G>A and c.-233+25C>G variants
between  the  two  groups.  The  variant  c.-233+25C>G  was
significant between patients and controls (p=6.815e−06), but
variant  c.-284G>A  was  not  significant  (p=0.153).  In
additional, we included another 51 control individuals for the
c.-284G>A variant. We found the c.-284G>A variant in 30
normal control individuals, including five (4.9%; 5/102) who
were  homozygous  and  25  (24.5%;  25/102)  who  were
heterozygous.  These  results,  the  allelic  and  genotypic
frequencies of the c.-284G>A variant between the two groups,
are similar with the 51 normal control individuals (data not
shown). Taken together, we suggested that the c.-284G>A
variant  may  not  be  a  risk  factor  for  JOAG  and  the
c.-233+25C>G variant may be protective against glaucoma in
the Taiwanese.
DISCUSSION
Information regarding the role that MYOC and OPTN play in
the development of JOAG in Taiwanese is insufficient. In our
previous study, we identified four MYOC mutations and six
polymorphisms  in  Taiwanese  patients  with  JOAG.  The
prevalence  of  MYOC  gene  mutations  was  12.5%  [21].
However, the contribution of OPTN sequence variations to
JOAG in Taiwan has not been analyzed. In this study, we
found 15 variants of OPTN in the 51 JOAG patients and in the
51 unrelated normal controls. Two were missense variants
(M98K and K322E), one was a synonymous codon change
(T34T), and 12 were changes in the noncoding sequences.
In previous studies, at least seven mutations of OPTN
have been reported to be associated with adult-onset POAG
[13,14,22]. Of the seven OPTN mutations that have been
identified in patients with adult-onset POAG, one is located
in exon 4 (E50K) [13,21], one is located in exon 5 (E103D)
[14], two are located in exon 6 (c.691_692insAG and V148V)
[13,14,22], one is located in exon 14 (H486R) [14], one is
located in exon 16 (R545Q) [13,22], and one is located in
intron  13  (IVS  13+21C>G)  [14].  Although  none  of  the
aforementioned mutations were detected in this study, we
identified 15 sequence variants of OPTN. These sequence
changes  are  not  classified  as  causative  mutations  but  as
polymorphisms because the frequencies were similar between
the patient and normal control groups.
Previous reports have indicated that mutations of OPTN
are  responsible  for  moderate  to  mild  forms  of  late  onset
glaucoma  and  are  specific  for  normal  tension  glaucoma
(NTG) [13]. OPTN mutations have been found in 16.7% of
patients with the hereditary form of NTG and in about 1%–
2% of patients with sporadic POAG [13,14,23]. However, two
subsequent studies on Caucasian POAG patients, one study
involving 801 patients of variable age onset [23] and one
TABLE 3. VARIANTS OF THE OPTN GENE IN THIS STUDY.
Genotype variants Amino acid variants Location Predicted effect Reference
c.-284G>A N Exon 1 — This study
c.-105G.>A N Exon 2 — This study
c.102G>A T34T Exon 4 synonymous change [13]
c.293T>A M98K Exon 5 missense change [13]
c.964A>G K322E Exon 10 missense change This study
c.-233+25C>G N Intron 1 — This study
c.166+66A>G N Intron 4 — This study
c.553–5C>T N Intron 6 — [14,31]
c.553–10G>A N Intron 6 — [14]
c.626+24G>A N Intron 7 — [14]
c.708–53T>C N Intron 7 — This study
c.779+20G>A N Intron 8 — [14]
c.882+109A>G N Intron 9 — This study
c.1978+101A>C N Intron 15 — This study
c.1979–48C>A N Intron 15 — [14]
Fifteen variants of OPTN were determined in the 51 JOAG patients and 51 unrelated normal controls. Two were missense
variants (M98K and K322E), one was a synonymous codon change (T34T), and 12 were changes in the noncoding sequences.
In addition, seven of the variants have been reported that it was indicated in reference position and eight were novel. The “N”
indicates that the variant had no change in amino acid. The “dash” indicates that the variant had no determined effect.
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490involving 86 adult-onset patients [24], found no glaucoma-
causing mutations in OPTN. In Japan, 148 patients with NTG
and  165  with  hypertension  glaucoma  had  no  specific
glaucoma-causing mutations in OPTN [25]. In addition, a
report also indicated that no mutation of OPTN was associated
with JOAG patients in the Philippines [26]. Our results are
TABLE 4. GENOTYPE FREQUENCIES OF OPTN VARIANTS IN JOAG PATIENTS AND NORMAL CONTROL INDIVIDUALS.
Genotype variants Allele 1/ Allele 2 JOAG, % (n=51) Control, % (n=51) p-Value* p-Value#
c.-284G>A G/G 66.7 (34/51) 70.6 (36/51)
G/A 13.7 (7/51) 25.5 (13/51) 0.023 0.153
A/A 19.6 (10/51) 3.9 (2/51)
c.-233+25C>G C/C 100 (51/51) 62.7 (32/51)
C/G 0 (0/51) 25.5 (13/51) <0.001 6.815e-06
G/G 0 (0/51) 11.8 (6/51)
c.-105G>A G/G 84.3 (43/51) 92.2 (47/51)
G/A 9.8 (5/51) 7.8 (4/51) 0.299 0.106
A/A 5.9 (3/51) 0 (0/51)
c.102G>A G/G 64.7 (33/51) 68.6 (35/51)
G/A 33.3 (17/51) 23.6 (12/51) 0.253 0.864
A/A 2.0 (1/51) 7.8 (4/51)
c.166+66A>G A/A 64.7 (33/51) 68.6 (35/51)
A/G 33.3 (17/51) 23.5 (12/51) 0.253 0.864
G/G 2.0 (1/51) 7.8 (4/51)
c.293T>A T/T 66.7 (34/51) 72.6 (37/51)
T/A 23.5 (12/51) 23.5 (12/51) 0.571 0.329
A/A 9.8 (5/51) 3.9 (2/51)
c.553–5C>T C/C 2.0 (1/51) 0 (0/51)
C/T 31.3 (16/51) 41.2 (21/51) 0.410 0.557
T/T 66.7 (34/51) 58.8 (30/51)
c.553–10G>A G/G 92.1 (47/51) 78.5 (40/51)
G/A 5.9 (3/51) 17.6 (9/51) 0.141 0.079
A/A 2.0 (1/51) 3.9 (2/51)
c.626+24G>A G/G 96.1 (49/51) 84.3 (43/51)
G/A 3.9 (2/51) 15.7 (8/51) 0.092 0.050
A/A 0 (0/51) 0 (0/51)
c.779+20G>A G/G 84.3 (43/51) 86.3 (44/51)
G/A 15.7 (8/51) 13.7 (7/51) >0.999 0.779
A/A 0 (0/51) 0 (0/51)
c.882+109A>G A/A 52.9 (27/51) 35.3(18/51)
A/G 35.3 (18/51) 43.1 (22/51) 0.164 0.057
G/G 11.8 (6/51) 21.6 (11/51)
c.708–53T>C T/T 92.2 (47/51) 86.2 (44/51)
T/C 3.9 (2/51) 2.0 (1/51) 0.446 0.212
C/C 3.9 (2/51) 11.8 (6/51)
c.964A>G A/A 0 (0/51) 0 (0/51)
A/G 0 (0/51) 0 (0/51) 1.000 NA
G/G 100 (51/51) 100 (51/51)
c.1978+101A>C A/A 47.1 (24/51) 54.9 (28/51)
A/C 47.1 (24/51) 37.3 (19/51) 0.669 0.632
C/C 5.8 (3/51) 7.8 (4/51)
c.1979–48C>A C/C 62.7 (32/51) 58.8 (30/51)
C/A 25.5 (13/51) 27.5 (14/51) 0.920 0.676
A/A 11.8 (6/51) 13.7 (7/51)
Fisher’s two-tailed exact test (p Value*) and Armitage's trend test (p Value#) were used to compare the genotype frequencies
of various sequence changes between JOAG and control subjects. Genotype frequency of c.-284G>A variant was shown to be
significant between two groups using Fisher’s two-tailed exact test (p=0.023; p<0.05). However, we used Armitage's trend test
to compare the genotypic frequency of the c.-284G>A variant was not significant (p=0.153). In addition, the c.-233+25C>G
genotype frequency was shown to be significant between two groups using Fisher’s two-tailed exact test (p<0.001) and
Armitage's trend test (p=6.815e-06). Apart from c.-284G>A and c.-233+25C>G, the other 13 variants did not differ significantly
between patients and controls (p>0.05).
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491consistent with those reported by Wang et al. [26] who found
that  OPTN  mutations  were  absent  in  JOAG  patients.
Therefore, we suggest that OPTN mutations are not related to
the development of JOAG in Taiwanese.
The M98K variant of OPTN was reported to be associated
with POAG in patients with normal or elevated IOP. The allele
frequency of the M98K variant was 13.6% in POAG patients
and only 2.1% in the control population. The result indicated
that M98K was very strongly associated with glaucoma [13].
In our study, M98K was found in 33.3% of JOAG patients
(17/51) and 27.5% of individuals in the control group (14/51);
however, the frequency of the M98K variant did not differ
significantly between patients and controls (p=0.571). In fact,
investigations of the OPTN M98K variant in patients with
POAG have yielded conflicting findings so far. Recently, a
meta-analysis of all published works to date on the OPTN
M98K variant in glaucoma patients did not show a strong role
for  the  OPTN  M98K  variant  in  glaucoma,  autosomal
dominant optic atrophy (ADOA), or Leber hereditary optic
neuropathy  (LHON)  [27].  In  addition,  a  large  study  that
investigated the allele frequencies of the M98K variant in
OPTN  also  found  no  significant  differences  in  allele
frequencies between POAG patients and controls in Asian,
African, Hispanic, or Caucasian populations [22]. However,
some  studies  have  indicated  that  the  M98K  variant  is
associated with POAG within populations in Japan [22,28]
and Europe [29]. Thus, Ayala-Lugo et al. [22] suggested that
ancestry is a significant confounding variable. In addition,
Melki et al. [30] reported that M98K was associated with
decreased initial intraocular pressure (IOP) in French patients
but was not significantly associated with decreased IOP in
Moroccan patients. Therefore, we believe that the association
TABLE 5. ALLELE FREQUENCIES OF OPTN VARIANTS IN THIS STUDY.
Variants Allele Frequency (%) Genotype
Genotype JOAG (n=102) Control (n=1–2) p-value JOAG (n=51) Control (n=51)
c.-284G>A G: 0.74 G: 0.83 0.089 10/7/1934 2/13/1936
A: 0.26 A: 0.17
c.-233+25C>G C: 1.00 C: 0.75 <0.001 0/0/51 6/13/1932
G: 0.00 G: 0.25
c.-105G.>A G: 0.83 G: 0.96 0.06 3/5/1943 0/4/47
A: 0.17 A: 0.04
c.102G>A G: 0.81 G: 0.80 0.859 1/17/1933 4/12/1935
A: 0.19 A: 0.20
c. IVS4+66A>G A: 0.81 A: 0.80 0.859 1/17/1933 4/12/1935
G: 0.19 G: 0.20
c.293T>A T: 0.78 T: 0.84 0.281 5/12/1934 2/12/1937
A: 0.22 A: 0.16
c.553–5C>T C: 0.18 C: 0.21 0.254 34/16/1 30/21/0
T: 0.72 T: 0.79
c.553–10G>A G: 0.95 G:0.87 0.048 1/3/1947 2/9/1940
A: 0.05 A:0.13
c.626+24G>A G: 0.98 G:0.95 0.618 0/2/49 0/8/43
A: 0.02 A:0.05
c.779+20G>A G: 0.92 G:0.93 0.249 0/8/43 0/7/44
A: 0.08 A:0.07
c.882+109A>G A: 0.53 A:0.57 0.789 6/18/2027 11/22/2018
G: 0.47 G:0.43
c.708–53T>C T: 0.94 T:0.87 0.574 2/2/1947 6/1/1944
C: 0.06 C:0.13
c.964A>G A: 0.00 A:0.00 1 51/0/0 51/0/0
G: 1.00 G:1.00
c.1978+101A>C A: 0.71 A:0.74 0.64 3/24/2024 4/19/2028
C: 0.29 C:0.26
c.1979–48C>A C: 0.75 C:0.73 0.632 6/13/1932 7/14/1930
A: 0.25 A:0.27
All subjects were screened and scored for each variant listed. Fisher’s two-tailed exact test was used to compare the allele
frequencies of various sequence changes between JOAG and control subjects. The genotype numbers indicate homozygote
variant/heterozygote variant/no variant.
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492between the M98K variant and glaucoma can be attributed to
racial variation. Based on our results and those from previous
studies,  the  M98K  variant  of  OPTN  is  not  a  risk  factor
associated with JOAG in Taiwan.
In our study, the c.-233+25C>G variant was identified in
the 19 normal control individuals but was not found in the
JOAG individuals. Thirteen of the control individuals (25.5%;
13/51) were homozygous, and six of the control individuals
(11.8%;  6/51)  were  heterozygous  for  c.-233+25C>G.  The
c.-233+25C>G allele frequencies and genotype frequencies
were  shown  to  be  significant  between  two  groups  using
Fisher’s two-tailed exact test (p<0.001) and Armitage's trend
test (p=6.815e−06; shown in Table 4 and Table 5). Therefore,
we suggest that the c.-233+25C>G variant may be protective
against glaucoma in the Taiwanese. Further research into this
association  would  be  interesting.  Expression  studies  and
functional assays may be needed to determine whether these
sequence variants play a role as transcription activators or
inhibitors. This might ultimately shed light on the mechanisms
relevant to the development of glaucoma. In addition, A964
nucleotide  of  OPTN  has  been  reported  in  GenBank
NM_001008211.  In  contrast,  the  G964  nucleotides  were
found in all patients with JOAG and in all normal controls in
our study. One possible explanation for such a difference in
nucleotides is attributed to racial variations. Therefore, the c.
964A>G variant is not associated with JOAG.
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